ETFs with exposure to Digirad Corp. : October 4, 2017

ETFs with exposure to Digirad Corp.

Here are 5 ETFs with the largest exposure to DRAD-US. Comparing the performance and risk of Digirad Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility.

Ticker Fund Name DRAD-US Exposure (%) 1 Year Price Performance (%) 1 Year Volatility (%) Net Expense Ratio (%) Number of Holdings
WMCR-US Wilshire Micro-Cap ETF 0.08 22.31 12.17 0.59 801
JSML-US Janus Small Cap Growth Alpha ETF 0.04 18.12 13.87 0.5 204
IWC-US iShares Micro-Cap ETF 0.02 22.57 14.27 0.6 1408
JSMD-US Janus Small/Mid Cap Growth Alpha ETF 0.01 21.81 16.65 0.5 256
VXF-US Vanguard Extended Market ETF 0 18.44 11.11 0.08 3186
DRAD-US Digirad Corp. 100 -33.46 0.68 0 1

Use our ETF screener to find ETFs that hold DRAD-US along with other stocks

ETFs with exposure to stocks in the same focus area as Digirad Corp..

Here are 5 ETFs with the largest exposure to stocks in the same focus area and region as DRAD-US. These ETFs may not have the highest percentage of Digirad Corp., but offer a broader sector/region exposure further minimizing single stock risk. Comparing the performance and risk of Digirad Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility.

Ticker Fund Name DRAD-US Exposure (%) Sector Exposure (%) 1 Year Price Performance (%) 1 Year Volatility (%) Net Expense Ratio (%) Number of Holdings
IHI-US iShares U.S. Medical Devices ETF 0 56.58 16.44 11.96 0.43 52
XHE-US SPDR S&P Health Care Equipment ETF 0 26.15 22.83 13.86 0.35 69
ZUH-CN BMO Equal Weight US Health Care Hedged to CAD Index ETF 0 21.52 13.35 10.87 0.4 56
QRH-CN Questrade Russell 1000 Equal Weight US Health Care Index ETF Hedged to CAD 0 21.48 12.79 14.64 0.7 54
RYH-US Guggenheim S&P 500 Equal Weight Healthcare ETF 0 20.79 13.75 11.04 0.4 63
DRAD-US Digirad Corp. 100 100 -33.46 0.68 0 1

Use our natural language search to find ETFs in any focus area

Disclaimer

The information presented in this report has been obtained from sources deemed to be reliable, but AnalytixInsight does not make any representation about the accuracy, completeness, or timeliness of this information. This report was produced by AnalytixInsight for informational purposes only and nothing contained herein should be construed as an offer to buy or sell or as a solicitation of an offer to buy or sell any security or derivative instrument. This report is current only as of the date that it was published and the opinions, estimates, ratings and other information may change without notice or publication. Past performance is no guarantee of future results. Prior to making an investment or other financial decision, please consult with your financial, legal and tax advisors. AnalytixInsight shall not be liable for any party’s use of this report. AnalytixInsight is not a broker-dealer and does not buy, sell, maintain a position, or make a market in any security referred to herein. One of the principal tenets for us at AnalytixInsight is that the best person to handle your finances is you. By your use of our services or by reading any of our reports, you’re agreeing that you bear responsibility for your own investment research and investment decisions. You also agree that AnalytixInsight, its directors, its employees, and its agents will not be liable for any investment decision made or action taken by you and others based on news, information, opinion, or any other material generated by us and/or published through our services. For a complete copy of our disclaimer, please visit our website www.analytixinsight.com.

*Disclaimer : This is as of previous day’s close